Klick Health lends expertise to COVID-19 digital health tools
The Number One agency on our Agency 100 list is collaborating with outside organizations to develop digital tools to help combat COVID-19.
The Number One agency on our Agency 100 list is collaborating with outside organizations to develop digital tools to help combat COVID-19.
Sander Flaum discusses the DISARM act and how we can fight back against antibiotic resistance.
As the country contends with the spread of the coronavirus, China’s next decade will see the evolution of health policy and regulation.
Several candidates relegated to the R&D graveyard re-emerged from their tombs this year and now headline the pharma developmental slate for 2020.
IQVIA examined the research and development landscape of 2018.
The holding company health unit will work with the university on its initiatives around the world.
Sander Flaum explains why continued research depends on fair prices for treatments.
Three of the industry’s top data architects reflect on their careers, opine on pharma’s “data revolution,” muse on the future of AI in healthcare, and unravel the secrets of their universe.
Caregivers are intimately involved in patient health, and that includes deciding on treatments, a new study suggests.
Vanessa Thirion-Cullity is executive director, U.S. NET of Novartis Oncology.